These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27964902)

  • 21. From laminar to turbulent flow in a dry powder inhaler: The effect of simple design modifications.
    Singh G; Tang P; Cheng S; Chan HK; Kourmatzis A
    Int J Pharm; 2022 Mar; 616():121556. PubMed ID: 35131350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A counter-swirl design concept for dry powder inhalers.
    Chaugule V; Dos Reis LG; Fletcher DF; Young PM; Traini D; Soria J
    Int J Pharm; 2024 Jan; 650():123694. PubMed ID: 38081562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of holding position during inhalation on drug release from a reservoir-, blister- and capsule-type dry powder inhaler.
    Kondo T; Tanigaki T; Yokoyama H; Hibino M; Tajiri S; Akazawa K; Yamada Y; Cassan SM
    J Asthma; 2017 Oct; 54(8):792-797. PubMed ID: 27929704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.
    Buttini F; Hannon J; Saavedra K; Rossi I; Balducci AG; Smyth H; Clark A; Colombo P
    Pharm Res; 2016 Dec; 33(12):3012-3020. PubMed ID: 27623625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining experimental and computational techniques to understand and improve dry powder inhalers.
    Chaugule V; Wong CY; Inthavong K; Fletcher DF; Young PM; Soria J; Traini D
    Expert Opin Drug Deliv; 2022 Jan; 19(1):59-73. PubMed ID: 34989629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M; Ho S; Muddle J; Buttini F; Parry M; Hammond M; Forbes B
    Int J Pharm; 2015 Jul; 490(1-2):360-7. PubMed ID: 25987210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of dry powder aerosolization mechanisms in different channel designs.
    Chen L; Heng RL; Delele MA; Cai J; Du DZ; Opara UL
    Int J Pharm; 2013 Nov; 457(1):143-9. PubMed ID: 24055441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Numerical Study on Particle Adhesion in Dry Powder Inhaler Device.
    Mitani R; Ohsaki S; Nakamura H; Watano S
    Chem Pharm Bull (Tokyo); 2020; 68(8):726-736. PubMed ID: 32741913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiral mouthpiece design in a dry powder inhaler to improve aerosolization.
    Lee HJ; Kwon IH; Lee HG; Kwon YB; Woo HM; Cho SM; Choi YW; Chon J; Kim K; Kim DW; Park CW
    Int J Pharm; 2018 Dec; 553(1-2):149-156. PubMed ID: 30336185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.
    Longest W; Farkas D; Bass K; Hindle M
    Pharm Res; 2019 May; 36(8):110. PubMed ID: 31139939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.
    Yakubu SI; Assi KH; Chrystyn H
    Int J Pharm; 2013 Oct; 455(1-2):213-8. PubMed ID: 23892154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Texture and Surface Chemistry on Deagglomeration and Powder Retention in Capsule-Based Dry Powder Inhaler.
    Groß R; Berkenfeld K; Schulte C; Ebert A; Sule S; Sule A; Lamprecht A
    AAPS PharmSciTech; 2022 Oct; 23(7):281. PubMed ID: 36241775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow and particle deposition in the Turbuhaler: a CFD simulation.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2013 May; 448(1):205-13. PubMed ID: 23528279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Genuair® inhaler: a novel, multidose dry powder inhaler.
    Chrystyn H; Niederlaender C
    Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prerequisites for a dry powder inhaler for children with cystic fibrosis.
    Lexmond AJ; Hagedoorn P; Frijlink HW; Rottier BL; de Boer AH
    PLoS One; 2017; 12(8):e0183130. PubMed ID: 28800360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A personalized medicine approach to the design of dry powder inhalers: Selecting the optimal amount of bypass.
    Kopsch T; Murnane D; Symons D
    Int J Pharm; 2017 Aug; 529(1-2):589-596. PubMed ID: 28743094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
    von Schantz S; Katajavuori N; Antikainen O; Juppo A
    Int J Pharm; 2016 Jul; 509(1-2):50-58. PubMed ID: 27208655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.